CONMED
CNMD
240 hedge funds and large institutions have $2.34B invested in CONMED in 2020 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 69 increasing their positions, 90 reducing their positions, and 26 closing their positions.
110% more call options, than puts
Call options by funds: $4.26M | Put options by funds: $2.03M
54% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 26
10% more capital invested
Capital invested by funds: $2.13B → $2.34B (+$213M)
6% more funds holding
Funds holding: 227 → 240 (+13)
2.32% more ownership
Funds ownership: 103.75% → 106.07% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 90
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
+$91M |
| 2 |
New York State Common Retirement Fund
Albany,
New York
|
+$18.1M |
| 3 |
Axa
Paris,
France
|
+$13.2M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$10.8M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$8.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24.1M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$10.7M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$10.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.93M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$8.69M |
CNMD Hedge Fund Activity: Q3 2020 in Review
240 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2020, worth a combined $2.34B — up 10% from $2.13B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new CNMD positions and 26 closed out — a net gain of 14 holders — while 69 added to existing stakes and 90 trimmed.
The largest buyer was EARNEST Partners, opening a new position worth an estimated $91M. The largest seller was Point72 Asset Management, cutting an estimated $24.1M.
- 240 institutional investors held CONMED (CNMD) as of Q3 2020, up from 227 in Q2 2020.
- Funds reported $2.34B of CONMED stock for Q3 2020, up 10% quarter-over-quarter.
- 40 funds opened new CONMED positions in Q3 2020 and 26 closed out, a net change of +14 holders.
- The largest CONMED buyer in Q3 2020 was EARNEST Partners, an estimated $91M added.
- The largest CONMED seller in Q3 2020 was Point72 Asset Management, an estimated $24.1M sold.
Based on aggregated 13F filings for Q3 2020.